| Mutations in GANAB, encoding the glucosidase IIα subunit, cause autosomal-dominant polycystic kidney and liver disease B Porath, VG Gainullin, E Cornec-Le Gall, EK Dillinger, CM Heyer, ... The American Journal of Human Genetics 98 (6), 1193-1207, 2016 | 443 | 2016 |
| Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity K Hopp, CJ Ward, CJ Hommerding, SH Nasr, HF Tuan, VG Gainullin, ... The Journal of clinical investigation 122 (11), 4257-4273, 2012 | 393 | 2012 |
| Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease S Rossetti, VJ Kubly, MB Consugar, K Hopp, S Roy, SW Horsley, ... Kidney international 75 (8), 848-855, 2009 | 334 | 2009 |
| Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease E Cornec-Le Gall, RJ Olson, W Besse, CM Heyer, VG Gainullin, JM Smith, ... The American Journal of Human Genetics 102 (5), 832-844, 2018 | 280 | 2018 |
| Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria K Hopp, AG Cogal, EJ Bergstralh, BM Seide, JB Olson, AM Meek, ... Journal of the American Society of Nephrology 26 (10), 2559-2570, 2015 | 246 | 2015 |
| Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing S Rossetti, K Hopp, RA Sikkink, JL Sundsbak, YK Lee, V Kubly, ... Journal of the American Society of Nephrology 23 (5), 915-933, 2012 | 201 | 2012 |
| Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD M Vujic, CM Heyer, E Ars, K Hopp, A Markoff, C Örndal, B Rudenhed, ... Journal of the American Society of Nephrology 21 (7), 1097-1102, 2010 | 182 | 2010 |
| Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease CM Heyer, JL Sundsbak, KZ Abebe, AB Chapman, VE Torres, ... Journal of the American Society of Nephrology 27 (9), 2872-2884, 2016 | 170 | 2016 |
| Food restriction ameliorates the development of polycystic kidney disease G Warner, KZ Hein, V Nin, M Edwards, CCS Chini, K Hopp, PC Harris, ... Journal of the American Society of Nephrology 27 (5), 1437-1447, 2016 | 156 | 2016 |
| Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner VG Gainullin, K Hopp, CJ Ward, CJ Hommerding, PC Harris The Journal of clinical investigation 125 (2), 607-620, 2015 | 140 | 2015 |
| Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model K Hopp, CJ Hommerding, X Wang, H Ye, PC Harris, VE Torres Journal of the American Society of Nephrology 26 (1), 39-47, 2015 | 129 | 2015 |
| B9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysis K Hopp, CM Heyer, CJ Hommerding, SA Henke, JL Sundsbak, S Patel, ... Human molecular genetics 20 (13), 2524-2534, 2011 | 96 | 2011 |
| Cancer cell–intrinsic expression of MHC class II regulates the immune microenvironment and response to anti–PD-1 therapy in lung adenocarcinoma AM Johnson, BL Bullock, AJ Neuwelt, JM Poczobutt, RE Kaspar, HY Li, ... The Journal of Immunology 204 (8), 2295-2307, 2020 | 84 | 2020 |
| Metabolic reprogramming in autosomal dominant polycystic kidney disease: evidence and therapeutic potential KL Nowak, K Hopp Clinical Journal of the American Society of Nephrology 15 (4), 577-584, 2020 | 78 | 2020 |
| Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 families BM Paul, MB Consugar, MR Lee, JL Sundsbak, CM Heyer, S Rossetti, ... Kidney international 85 (2), 383-392, 2014 | 74 | 2014 |
| Effects of hydration in rats and mice with polycystic kidney disease K Hopp, X Wang, H Ye, MV Irazabal, PC Harris, VE Torres American Journal of Physiology-Renal Physiology 308 (3), F261-F266, 2015 | 61 | 2015 |
| Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease K Hopp, E Cornec-Le Gall, SR Senum, IBAW Te Paske, S Raj, S Lavu, ... Kidney international 97 (2), 370-382, 2020 | 60 | 2020 |
| CD8+ T cells modulate autosomal dominant polycystic kidney disease progression EK Kleczko, KH Marsh, LC Tyler, SB Furgeson, BL Bullock, CJ Altmann, ... Kidney international 94 (6), 1127-1140, 2018 | 58 | 2018 |
| HALT Progression of Polycystic Kidney Disease Group; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease: Mutations in GANAB, encoding the glucosidase IIα … B Porath, VG Gainullin, E Cornec-Le Gall, EK Dillinger, CM Heyer, ... Am J Hum Genet 98 (6), 1193-1207, 2016 | 54 | 2016 |
| Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti–PD-1 response in NSCLC BL Bullock, AK Kimball, JM Poczobutt, AJ Neuwelt, HY Li, AM Johnson, ... Life science alliance 2 (3), 2019 | 48 | 2019 |
Vlad GainullinExact SciencesVerified email at exactsciences.com
